HealthFinSMEsabout 1 hour ago
Fathom Therapeutics Gets Kos Investment
1 min read
Fathom Therapeutics receives investment from Kos Biotechnology Partners as part of its Series A financing led by Sutter Hill Ventures. The company plans to use funds to scale its platform and advance its internal pipeline. CEO Huafeng Xu leads the firm.
Level
Hype check
Tap to vote and see what everyone thinks.